The Potential Links Between LncRNAs and Drug Tolerance in Lung Adenocarcinoma

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2024 Jul 27

PMID 39062685

Authors

William J H Davis

Catherine J Drummond

Sarah Diermeier

Glen Reid

Affiliations

Soon will be listed here.

Abstract

Lung cancer patients treated with targeted therapies frequently respond well but invariably relapse due to the development of drug resistance. Drug resistance is in part mediated by a subset of cancer cells termed "drug-tolerant persisters" (DTPs), which enter a dormant, slow-cycling state that enables them to survive drug exposure. DTPs also exhibit stem cell-like characteristics, broad epigenetic reprogramming, altered metabolism, and a mutagenic phenotype mediated by adaptive mutability. While several studies have characterised the transcriptional changes that lead to the altered phenotypes exhibited in DTPs, these studies have focused predominantly on protein coding changes. As long non-coding RNAs (lncRNAs) are also implicated in the phenotypes altered in DTPs, it is likely that they play a role in the biology of drug tolerance. In this review, we outline how lncRNAs may contribute to the key characteristics of DTPs, their potential roles in tolerance to targeted therapies, and the emergence of genetic resistance in lung adenocarcinoma.

References

Taiana E, Ronchetti D, Todoerti K, Nobili L, Tassone P, Amodio N . LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?. Noncoding RNA. 2020; 6(3). PMC: 7549348. DOI: 10.3390/ncrna6030026. View

Merry C, Forrest M, Sabers J, Beard L, Gao X, Hatzoglou M . DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet. 2015; 24(21):6240-53. PMC: 4599679. DOI: 10.1093/hmg/ddv343. View

Mattick J, Amaral P, Carninci P, Carpenter S, Chang H, Chen L . Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023; 24(6):430-447. PMC: 10213152. DOI: 10.1038/s41580-022-00566-8. View

Zhang P, Dong Q, Zhu H, Li S, Shi L, Chen X . Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression. Gene. 2019; 696:1-9. DOI: 10.1016/j.gene.2018.12.079. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Singh N, Ramnarine V, Song J, Pandey R, Padi S, Nouri M . The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021; 12(1):7349. PMC: 8692330. DOI: 10.1038/s41467-021-26901-9. View

Clemson C, Hutchinson J, Sara S, Ensminger A, Fox A, Chess A . An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009; 33(6):717-26. PMC: 2696186. DOI: 10.1016/j.molcel.2009.01.026. View

Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg A . Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008; 451(7175):202-6. PMC: 2743558. DOI: 10.1038/nature06468. View

Perez-Pinera P, Kocak D, Vockley C, Adler A, Kabadi A, Polstein L . RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013; 10(10):973-6. PMC: 3911785. DOI: 10.1038/nmeth.2600. View

10.

Huang W, Li H, Yu Q, Xiao W, Wang D . LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond. J Exp Clin Cancer Res. 2022; 41(1):100. PMC: 8922926. DOI: 10.1186/s13046-022-02319-z. View

11.

Kunimasa K, Nagano T, Shimono Y, Dokuni R, Kiriu T, Tokunaga S . Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters. Cancer Sci. 2017; 108(7):1368-1377. PMC: 5497794. DOI: 10.1111/cas.13266. View

12.

Fan X, Wang Y, Zhao W, Bai S, Ma Y, Yin X . NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation. Am J Cancer Res. 2021; 11(6):2838-2852. PMC: 8263645. View

13.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

14.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

15.

Brown N, Korolchuk S, Martin M, Stanley W, Moukhametzianov R, Noble M . CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. Nat Commun. 2015; 6:6769. PMC: 4413027. DOI: 10.1038/ncomms7769. View

16.

Guler G, Tindell C, Pitti R, Wilson C, Nichols K, KaiWai Cheung T . Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. Cancer Cell. 2017; 32(2):221-237.e13. DOI: 10.1016/j.ccell.2017.07.002. View

17.

Faget D, Ren Q, Stewart S . Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019; 19(8):439-453. DOI: 10.1038/s41568-019-0156-2. View

18.

van Bakel H, Nislow C, Blencowe B, Hughes T . Most "dark matter" transcripts are associated with known genes. PLoS Biol. 2010; 8(5):e1000371. PMC: 2872640. DOI: 10.1371/journal.pbio.1000371. View

19.

Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann K, Speicher D . Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013; 23(6):811-25. PMC: 3810180. DOI: 10.1016/j.ccr.2013.05.003. View

20.

Balaban N, Merrin J, Chait R, Kowalik L, Leibler S . Bacterial persistence as a phenotypic switch. Science. 2004; 305(5690):1622-5. DOI: 10.1126/science.1099390. View